Last reviewed · How we verify
NCT03409497
Effects of Grape Juice With Breakfast on Glycemia and Cognitive Function in Healthy Adults
NA trial testing Concord Grape Juice in Glycemic Response in 40 participants. Completed in 30 June 2020.
28 October 2019
Quick facts
| Lead sponsor | Purdue University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | single |
| Primary purpose | basic science |
| Enrollment | 40 |
| Start date | 17 May 2019 |
| Primary completion | 28 October 2019 |
| Estimated completion | 30 June 2020 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Concord Grape Juice
- Low flavonoid low essence beverage
- Low flavonoid beverage — full drug profile →
Conditions studied
- Glycemic Response — all drugs for Glycemic Response →
- Appetitive Behavior — all drugs for Appetitive Behavior →
Sponsor
Purdue University
Who can join
Adults 25 to 60, any sex, with Glycemic Response or Appetitive Behavior. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Assess the impact of 100% grape juice with a meal on postprandial glycemic response and subsequent appetite, food intake and cognitive function.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Effects of Concord grape juice flavor intensity and phenolic compound content on glycemia, appetite and cognitive function in adults with excess body weight: a randomized double-blind crossover trial.
Coelho OGL, Alfenas RCG, Debelo H, Wightman JD, et al · · 2021 · cited 5× · PMID 34698750 · DOI 10.1039/d1fo02049h
Verify or expand the search:
- PubMed search for NCT03409497
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Concord Grape Juice
Trials testing the same drug.
- NCT03409484 — Effects of Concord Grape Juice Alone on Glycemia, Appetite and Cognitive Function in Healthy Adults · NA · completed
Other recruiting trials for Glycemic Response
Currently open trials in the same condition.
- NCT04881019 — PRediction Of Glycemic RESponse Study · active not recruiting
Other Purdue University trials
Trials by the same sponsor.
- NCT07287774 — Evaluating a Deep Neural Noise-Reduction Algorithm for Hearing Aids · NA · recruiting
- NCT07086833 — The Food Environment, Microbial Cysteine Metabolism, and Cancer Disparities · NA · recruiting
- NCT06638944 — Wearable Biofeedback for Swallowing Disorders Rehabilitation in Stroke and Parkinson Disease · Phase 2 · recruiting
- NCT07048392 — Retrieval-Based Word Learning in Developmental Language Disorder During Book Reading II · NA · recruiting
- NCT06258941 — Classroom Break, Cognition, and Fitness in Elementary School Children · Phase 1, PHASE2 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03409497 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Purdue University
- Last refreshed: 5 November 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03409497.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing